Ac-Aib-Asn-Ile-Ile-Aib-Pro-Leu-Leu-Aib-Pro-Leu-ol
| Internal ID | 23978de4-5924-4394-8f01-d1c1260ccbf0 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-2-[(2-acetamido-2-methylpropanoyl)amino]-N-[(2S,3S)-1-[[(2S,3S)-1-[[1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[1-[(2S)-2-[[(2S)-1-hydroxy-4-methylpentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]butanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C58H102N12O13/c1-18-34(9)44(64-47(75)40(29-43(59)73)63-53(81)56(12,13)66-36(11)72)51(79)65-45(35(10)19-2)52(80)68-58(16,17)55(83)70-25-21-23-42(70)50(78)62-38(27-32(5)6)46(74)61-39(28-33(7)8)48(76)67-57(14,15)54(82)69-24-20-22-41(69)49(77)60-37(30-71)26-31(3)4/h31-35,37-42,44-45,71H,18-30H2,1-17H3,(H2,59,73)(H,60,77)(H,61,74)(H,62,78)(H,63,81)(H,64,75)(H,65,79)(H,66,72)(H,67,76)(H,68,80)/t34-,35-,37-,38-,39-,40-,41-,42-,44-,45-/m0/s1 |
| InChI Key | SUJVHTVAUFPDNS-LRYCKQPWSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C58H102N12O13 |
| Molecular Weight | 1175.50 g/mol |
| Exact Mass | 1174.76893135 g/mol |
| Topological Polar Surface Area (TPSA) | 366.00 Ų |
| XlogP | 3.00 |
| Atomic LogP (AlogP) | 0.68 |
| H-Bond Acceptor | 13 |
| H-Bond Donor | 11 |
| Rotatable Bonds | 32 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6307 | 63.07% |
| Caco-2 | - | 0.8600 | 86.00% |
| Blood Brain Barrier | - | 0.6750 | 67.50% |
| Human oral bioavailability | - | 0.6143 | 61.43% |
| Subcellular localzation | Lysosomes | 0.6705 | 67.05% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8697 | 86.97% |
| OATP1B3 inhibitior | + | 0.9339 | 93.39% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 0.9750 | 97.50% |
| BSEP inhibitior | + | 0.9247 | 92.47% |
| P-glycoprotein inhibitior | + | 0.7428 | 74.28% |
| P-glycoprotein substrate | + | 0.8616 | 86.16% |
| CYP3A4 substrate | + | 0.7062 | 70.62% |
| CYP2C9 substrate | - | 0.7929 | 79.29% |
| CYP2D6 substrate | - | 0.8494 | 84.94% |
| CYP3A4 inhibition | - | 0.6870 | 68.70% |
| CYP2C9 inhibition | - | 0.8665 | 86.65% |
| CYP2C19 inhibition | - | 0.7879 | 78.79% |
| CYP2D6 inhibition | - | 0.8833 | 88.33% |
| CYP1A2 inhibition | - | 0.8821 | 88.21% |
| CYP2C8 inhibition | + | 0.4804 | 48.04% |
| CYP inhibitory promiscuity | - | 0.9641 | 96.41% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.7400 | 74.00% |
| Carcinogenicity (trinary) | Non-required | 0.6227 | 62.27% |
| Eye corrosion | - | 0.9802 | 98.02% |
| Eye irritation | - | 0.8966 | 89.66% |
| Skin irritation | - | 0.7762 | 77.62% |
| Skin corrosion | - | 0.8955 | 89.55% |
| Ames mutagenesis | - | 0.6500 | 65.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3952 | 39.52% |
| Micronuclear | + | 0.6600 | 66.00% |
| Hepatotoxicity | + | 0.6407 | 64.07% |
| skin sensitisation | - | 0.8557 | 85.57% |
| Respiratory toxicity | + | 0.7222 | 72.22% |
| Reproductive toxicity | + | 0.8222 | 82.22% |
| Mitochondrial toxicity | + | 0.7000 | 70.00% |
| Nephrotoxicity | + | 0.5411 | 54.11% |
| Acute Oral Toxicity (c) | III | 0.6368 | 63.68% |
| Estrogen receptor binding | + | 0.6888 | 68.88% |
| Androgen receptor binding | + | 0.7515 | 75.15% |
| Thyroid receptor binding | + | 0.5884 | 58.84% |
| Glucocorticoid receptor binding | + | 0.6842 | 68.42% |
| Aromatase binding | + | 0.7173 | 71.73% |
| PPAR gamma | + | 0.7771 | 77.71% |
| Honey bee toxicity | - | 0.8392 | 83.92% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.6800 | 68.00% |
| Fish aquatic toxicity | - | 0.6671 | 66.71% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3837 | P07711 | Cathepsin L | 99.76% | 96.61% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.60% | 98.95% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.80% | 97.25% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.58% | 96.09% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.55% | 98.94% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 98.36% | 97.43% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 98.28% | 96.67% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.12% | 98.33% |
| CHEMBL4801 | P29466 | Caspase-1 | 97.51% | 96.85% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.26% | 93.56% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 96.93% | 96.95% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.55% | 100.00% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 95.81% | 92.38% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.33% | 98.10% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 95.04% | 91.19% |
| CHEMBL3468 | P55210 | Caspase-7 | 94.98% | 95.68% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 94.83% | 99.77% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 94.77% | 94.66% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 94.65% | 96.31% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 94.49% | 94.00% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 94.03% | 97.21% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 93.99% | 96.03% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 93.95% | 97.50% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.51% | 97.64% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.37% | 100.00% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 93.27% | 98.89% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 93.21% | 97.14% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.08% | 100.00% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 92.93% | 95.38% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 92.74% | 92.12% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 92.53% | 96.67% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.33% | 97.09% |
| CHEMBL4461 | Q9NTG7 | NAD-dependent deacetylase sirtuin 3 | 91.23% | 94.36% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 90.91% | 96.47% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 90.36% | 95.52% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 89.95% | 97.47% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 88.20% | 94.33% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 88.11% | 98.24% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 87.20% | 88.42% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 87.20% | 83.14% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 86.61% | 95.89% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 86.38% | 99.17% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 86.24% | 98.05% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 86.08% | 83.10% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 85.62% | 86.67% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 85.26% | 90.93% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 85.11% | 97.23% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 84.41% | 96.21% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 84.09% | 96.90% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 83.90% | 90.71% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 83.64% | 98.75% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.09% | 100.00% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 83.05% | 89.50% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 82.84% | 98.57% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 82.82% | 93.00% |
| CHEMBL5028 | O14672 | ADAM10 | 82.76% | 97.50% |
| CHEMBL236 | P41143 | Delta opioid receptor | 82.58% | 99.35% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.55% | 95.50% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 82.26% | 99.17% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 81.92% | 91.81% |
| CHEMBL3691 | Q13822 | Autotaxin | 81.68% | 96.39% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 81.56% | 96.28% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 81.48% | 93.04% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 81.47% | 95.00% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 81.32% | 95.71% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 81.16% | 98.59% |
| CHEMBL5285 | Q99683 | Mitogen-activated protein kinase kinase kinase 5 | 81.09% | 92.26% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 81.05% | 97.50% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 80.42% | 95.89% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 80.21% | 95.27% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 80.08% | 99.18% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 80.02% | 93.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 10534341 |
| LOTUS | LTS0061867 |
| wikiData | Q105261005 |